Augmentin 375mg Tablets Medicine Buy Ayurslim Weight Regulator L Moteur De Recherche Sp Cialis Atarax 25 Mg Eureka Benadryl Pills Mg

///2018 Abstract Details
2018 Abstract Details2019-08-02T15:57:01-05:00

Case Report: The Use of Dexmedetomidine in the Management of a Parturient with Multiple Endocrine Neoplasia Requiring Multiple Intrapartum Non-Obstetric, Non-Gynecologic Surgeries

Abstract Number: F4C-10
Abstract Type: Case Report/Case Series

Amanda L Faulkner MD1 ; Eric Swanson MD2; Annette Rebel MD3; Christopher Mallard MD4; Kenneth T McCoun MD5; Regina Fragneto MD6

Dexmedetomidine, a pregnancy class C selective alpha-2 adrenoreceptor agonist, has previously been documented safe for use in the obstetric population for cesarean delivery and other peri-delivery gynecologic procedures; however, little has been documented about use in parturients undergoing non-obstetric surgeries. We present the perioperative management of a parturient with Multiple Endocrine Neoplasia 2a using dexmedetomidine as a novel intrapartum anesthetic adjunct while undergoing both an adrenalectomy for pheochromocytoma as well as a total thyroidectomy. As an adjunct for both operations, dexmedtomidine minimized exposure to medications undesirable in pregnancy, provided effective anxiolysis, and afforded hemodynamic stability unrelated to patient anxiety. Most importantly, our patient was able to successfully receive both operative interventions in her second trimester to likewise minimize fetal risk. The patient ultimately carried her fetus until 38 weeks and 3/7 days gestation. At that time, she underwent a scheduled repeat cesarean section via combined spinal-epidural anesthesia. A healthy female child was delivered with APGARs of 9 and 9 at one minute and five minutes respectfully. On day of life number three, both were discharged home in good condition.

SOAP 2018